Ani Pharmaceuticals (ANIP) Shareholder's Equity (2019 - 2023)
Ani Pharmaceuticals (ANIP) Shareholder's Equity (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Quarter) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 339.48 Mn |
| Dec 31, 2022 | 338.54 Mn |
| Sep 30, 2022 | 336.68 Mn |
| Jun 30, 2022 | 336.96 Mn |
| Mar 31, 2022 | 346.09 Mn |
| Dec 31, 2021 | 358.74 Mn |
| Sep 30, 2021 | 191.40 Mn |
| Jun 30, 2021 | 191.92 Mn |
| Dec 31, 2020 | 195.70 Mn |
| Dec 31, 2019 | 212.79 Mn |